Literature DB >> 9207388

Proteases from Aspergillus fumigatus induce release of proinflammatory cytokines and cell detachment in airway epithelial cell lines.

J F Tomee1, A T Wierenga, P S Hiemstra, H K Kauffman.   

Abstract

Aspergillus fumigatus is a pathogen causing diverse respiratory disorders. Several studies have suggested that fungal proteases may play a role in the pathogenicity of fungi. Since the airways are the most common route for entry of A. fumigatus, this study focused on the ability of fungal proteases to induce the release of proinflammatory cytokines and to cause cell detachment in human pulmonary epithelial cell lines. It was shown that fungal serine protease activity induced the production of interleukin (IL)-8 and IL-6 and monocyte chemotactic protein-1 and caused cell detachment in a dose-dependent fashion. Chymostatin, antipain, phenylmethylsulfonyl fluoride, and heat treatment completely inhibited fungal protease activity, cytokine production and cell detachment; antileukoprotease partially inhibited these activities. By causing cell detachment, fungal proteases may decrease the physical barrier function of the epithelium; however, by eliciting a cytokine response, the epithelium may signal the mucosal inflammatory response against A. fumigatus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9207388     DOI: 10.1086/517272

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  47 in total

1.  Aspergillus fumigatus chronic colonization and lung function decline in cystic fibrosis may have a two-way relationship.

Authors:  M Noni; A Katelari; G Dimopoulos; S-E Doudounakis; C Tzoumaka-Bakoula; V Spoulou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-08-30       Impact factor: 3.267

Review 2.  Innate immune responses to environmental allergens.

Authors:  Henk F Kauffman
Journal:  Clin Rev Allergy Immunol       Date:  2006-04       Impact factor: 8.667

3.  Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome.

Authors:  S S Weigt; R M Elashoff; C Huang; A Ardehali; A L Gregson; B Kubak; M C Fishbein; R Saggar; M P Keane; R Saggar; J P Lynch; D A Zisman; D J Ross; J A Belperio
Journal:  Am J Transplant       Date:  2009-05-13       Impact factor: 8.086

4.  Chymostatin can combine with pepstatin to eliminate extracellular protease activity in cultures of Aspergillus niger NRRL-3.

Authors:  Aftab Ahamed; Ajay Singh; Owen P Ward
Journal:  J Ind Microbiol Biotechnol       Date:  2006-12-20       Impact factor: 3.346

5.  Transcription factor PrtT controls expression of multiple secreted proteases in the human pathogenic mold Aspergillus fumigatus.

Authors:  Haim Sharon; Shelly Hagag; Nir Osherov
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

Review 6.  Severe asthma with fungal sensitization.

Authors:  Ritesh Agarwal
Journal:  Curr Allergy Asthma Rep       Date:  2011-10       Impact factor: 4.806

7.  Serratia marcescens serralysin induces inflammatory responses through protease-activated receptor 2.

Authors:  Yutaka Kida; Hiroyoshi Inoue; Takashi Shimizu; Koichi Kuwano
Journal:  Infect Immun       Date:  2006-10-16       Impact factor: 3.441

Review 8.  Allergic bronchopulmonary aspergillosis.

Authors:  Richard B Moss
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

Review 9.  Secretory leukoprotease inhibitor: a native antimicrobial protein presenting a new therapeutic option?

Authors:  J F Tomee; G H Koëter; P S Hiemstra; H F Kauffman
Journal:  Thorax       Date:  1998-02       Impact factor: 9.139

10.  Aspergillus fumigatus-induced interleukin-8 synthesis by respiratory epithelial cells is controlled by the phosphatidylinositol 3-kinase, p38 MAPK, and ERK1/2 pathways and not by the toll-like receptor-MyD88 pathway.

Authors:  Viviane Balloy; Jean-Michel Sallenave; Yongzheng Wu; Lhousseine Touqui; Jean-Paul Latgé; Mustapha Si-Tahar; Michel Chignard
Journal:  J Biol Chem       Date:  2008-08-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.